Using the same SLE xenograft model, we allowed for 4 weeks to establish human disease in immune-deficient mice followed by multiple t.v. injections of CD4+CD25+CD127low UCB-Tregs administered on days 30, 35, 45, and 51 (Figure 4A). This evidence concerns the gene CD4 and systemic lupus erythematosus.